175 related articles for article (PubMed ID: 14555701)
1. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Li C; Koley H; Hurley LH; Anderson KC; Munshi NC
Clin Cancer Res; 2004 Jan; 10(2):770-6. PubMed ID: 14760100
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
[TBL] [Abstract][Full Text] [Related]
4. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
6. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
7. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase.
Shi DF; Wheelhouse RT; Sun D; Hurley LH
J Med Chem; 2001 Dec; 44(26):4509-23. PubMed ID: 11741471
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Yamada H
Cancer Lett; 2008 Mar; 261(2):226-34. PubMed ID: 18096315
[TBL] [Abstract][Full Text] [Related]
9. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
12. The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.
Chen J; Jin X; Mei Y; Shen Z; Zhu J; Shi H; Wang M; Zheng X; Liang G
Cell Prolif; 2021 Sep; 54(9):e13101. PubMed ID: 34296479
[TBL] [Abstract][Full Text] [Related]
13. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Grand CL; Han H; Muñoz RM; Weitman S; Von Hoff DD; Hurley LH; Bearss DJ
Mol Cancer Ther; 2002 Jun; 1(8):565-73. PubMed ID: 12479216
[TBL] [Abstract][Full Text] [Related]
14. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
[TBL] [Abstract][Full Text] [Related]
15. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
16. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Gowan SM; Harrison JR; Patterson L; Valenti M; Read MA; Neidle S; Kelland LR
Mol Pharmacol; 2002 May; 61(5):1154-62. PubMed ID: 11961134
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin derivatives for telomere binding and telomerase inhibition.
Dixon IM; Lopez F; Estève JP; Tejera AM; Blasco MA; Pratviel G; Meunier B
Chembiochem; 2005 Jan; 6(1):123-32. PubMed ID: 15551357
[TBL] [Abstract][Full Text] [Related]
18. In vitro assays predictive of telomerase inhibitory effect of G-quadruplex ligands in cell nuclei.
Yaku H; Murashima T; Miyoshi D; Sugimoto N
J Phys Chem B; 2014 Mar; 118(10):2605-14. PubMed ID: 24328194
[TBL] [Abstract][Full Text] [Related]
19. Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231.
Konieczna N; Romaniuk-Drapała A; Lisiak N; Totoń E; Paszel-Jaworska A; Kaczmarek M; Rubiś B
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151281
[TBL] [Abstract][Full Text] [Related]
20. G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cells.
Shen Z; Zheng R; Yang H; Xing S; Jin X; Yan H; Zhu J; Mei Y; Lin F; Zheng X
Int J Biol Macromol; 2022 Jul; 213():858-870. PubMed ID: 35697164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
